Autologous Lymphokine-Activated Killer Cell Therapy of Epstein-Barr Virus-Positive and -Negative Lymphoproliferative Disorders Arising in Organ Transplant Recipients1

Transplantation - United States
doi 10.1097/00007890-199705150-00002

Related search